Anti‐TNFα induced lupus due to infliximab therapy in a patient with concurrent Crohn's disease
Abstract Anti‐TNFα inhibitor‐induced Lupus (ATIL) is a rare syndrome characterized by a wide array of symptoms ranging from skin manifestations to organ‐specific symptoms such as pleural effusions, pericardial effusions, hepatotoxicity, etc. Infliximab is implicated in most cases, and ATIL usually d...
Main Authors: | Akanksha Sharma, Taha Ahmed, Aashna Mehta, Julius Birnbaum, Abhigan Babu Shrestha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-07-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.7673 |
Similar Items
-
Antinuclear antibody-negative systemic lupus erythematosus
by: Krithiga Muralidharan, et al.
Published: (2023-01-01) -
Evaluation of Anti-Nuclear Antibodies and Anti-dsDNA Serum Levels in Patients with Suspected Systemic Lupus Erythematosus
by: Mana Zakeri, et al.
Published: (2023-03-01) -
Lymphoprolipherative skin reactions induced by anti-TNFα: an open question
by: Vasiliki Nikolaou, et al.
Published: (2020-01-01) -
Diagnostic Challenge in Distinguishing Crohn’s Disease from Lupus Enteritis in Systemic Lupus Erythematosus Patient: A Case Report
by: Eka Benhardi Layadi, et al.
Published: (2023-04-01) -
Kikuchi–Fujimoto disease followed by systemic lupus erythematosus in a male child: A diagnostic challenge
by: Sruthi Kodali, et al.
Published: (2024-01-01)